Obesity induced by high fat diet attenuates postinfarct myocardial remodeling and dysfunction in adult B6D2F1 mice

Journal of Molecular and Cellular Cardiology

Volumn 84, Issue , 2015, Pages 154-161

  Poncelas, Marcos ^a   Inserte, Javier ^a   Vilardosa, Úrsula ^a   Rodriguez Sinovas, Antonio ^a   Bañeras, Jordi ^a   Simó, Rafael ^b   Garcia Dorado, David ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Insulin; Myocardial infarction; Obesity; Remodeling

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; INSULIN; PROTEIN KINASE B; PROTEIN KINASE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; CORONARY ARTERY OCCLUSION; CORONARY REPERFUSION; ECHOCARDIOGRAPHY; ENZYME PHOSPHORYLATION; FEMALE; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART VENTRICLE REMODELING; HEART VENTRICLE SIZE; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTENSION; LIPID DIET; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; REPERFUSION INJURY; SIGNAL TRANSDUCTION; AGING; ANIMAL; COMPLICATION; ECHOGRAPHY; ELECTROCARDIOGRAPHY; ENZYME ACTIVATION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALIA; MUS;

AGING; ANIMALS; DIET, HIGH-FAT; ELECTROCARDIOGRAPHY; ENZYME ACTIVATION; MICE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; OBESITY; PROTEIN KINASES; SIGNAL TRANSDUCTION; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84928990047     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2015.04.023     Document Type: Article

References (58)

1. Maroko P.R., Libby P., Ginks W.R., Bloor C.M., Shell W.E., Sobel B.E., et al. Coronary artery reperfusion. I. Early effects on local myocardial function and the extent of myocardial necrosis. J Clin Invest 1972, 51:2710-2716.
2. Garcia-Dorado D., Piper H.M. Postconditioning: reperfusion of "reperfusion injury" after hibernation. Cardiovasc Res 2006, 69:1-3.
3. Vander Heide R.S., Steenbergen C. Cardioprotection and myocardial reperfusion: pitfalls to clinical application. Circ Res 2013, 113:464-477.
4. Nguyen T, Lau DC. The obesity epidemic and its impact on hypertension. Can J Cardiol.28:326-33.
5. Roos C.J., Quax P.H., Jukema J.W. Cardiovascular metabolic syndrome: mediators involved in the pathophysiology from obesity to coronary heart disease. Biomark Med 2012, 6:35-52.
6. Curtis J.P., Selter J.G., Wang Y., Rathore S.S., Jovin I.S., Jadbabaie F., et al. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med 2005, 165:55-61.
7. Oreopoulos A., Padwal R., Kalantar-Zadeh K., Fonarow G.C., Norris C.M., McAlister F.A. Body mass index and mortality in heart failure: a meta-analysis. Am Heart J 2008, 156:13-22.
8. Habbu A., Lakkis N.M., Dokainish H. The obesity paradox: fact or fiction?. Am J Cardiol 2006, 98:944-948.
9. Aronson D., Nassar M., Goldberg T., Kapeliovich M., Hammerman H., Azzam Z.S. The impact of body mass index on clinical outcomes after acute myocardial infarction. Int J Cardiol 2010, 145:476-480.
10. Guglin M., Baxi K., Schabath M. Anatomy of the obesity paradox in heart failure. Heart Fail Rev 2014, 19:621-635.
11. Chrysant S.G., Chrysant G.S. New insights into the true nature of the obesity paradox and the lower cardiovascular risk. J Am Soc Hypertens 2013, 7:85-94.
12. Banack H.R., Kaufman J.S. The "obesity paradox" explained. Epidemiology 2013, 24:461-462.
13. du Toit E.F., Smith W., Muller C., Strijdom H., Stouthammer B., Woodiwiss A.J., et al. Myocardial susceptibility to ischemic-reperfusion injury in a prediabetic model of dietary-induced obesity. Am J Physiol Heart Circ Physiol 2008, 294:H2336-H2343.
14. Essop M.F., Anna Chan W.Y., Valle A., Garcia-Palmer F.J., Du Toit E.F. Impaired contractile function and mitochondrial respiratory capacity in response to oxygen deprivation in a rat model of pre-diabetes. Acta Physiol (Oxf) 2009, 197:289-296.
15. Maarman G., Marais E., Lochner A., du Toit E.F. Effect of chronic CPT-1 inhibition on myocardial ischemia-reperfusion injury (I/R) in a model of diet-induced obesity. Cardiovasc Drugs Ther 2012, 26:205-216.
16. Wensley I., Salaveria K., Bulmer A.C., Donner D.G., du Toit E.F. Myocardial structure, function and ischaemic tolerance in a rodent model of obesity with insulin resistance. Exp Physiol 2013, 98:1552-1564.
17. Donner D., Headrick J.P., Peart J.N., du Toit E.F. Obesity improves myocardial ischaemic tolerance and RISK signalling in insulin-insensitive rats. Dis Model Mech 2013, 6:457-466.
18. Hausenloy D.J., Yellon D.M. Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection. Heart Fail Rev 2007, 12:217-234.
19. Huisamen B. Protein kinase B in the diabetic heart. Mol Cell Biochem 2003, 249:31-38.
20. Steinberg H.O., Chaker H., Leaming R., Johnson A., Brechtel G., Baron A.D. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 1996, 97:2601-2610.
21. Singhal A.K., Symons J.D., Boudina S., Jaishy B., Shiu Y.E. Role of Endothelial Cells in Myocardial Ischemia-Reperfusion Injury. Vasc Dis Prev 2010, 7:1-14.
22. Benavides-Vallve C., Corbacho D., Iglesias-Garcia O., Pelacho B., Albiasu E., Castano S., et al. New strategies for echocardiographic evaluation of left ventricular function in a mouse model of long-term myocardial infarction. PLoS One 2012, 7. [e41691].
23. Karasawa H., Nagata-Goto S., Takaishi K., Kumagae Y. A novel model of type 2 diabetes mellitus based on obesity induced by high-fat diet in BDF1 mice. Metabolism 2009, 58:296-303.
24. Lim S.Y., Hausenloy D.J., Arjun S., Price A.N., Davidson S.M., Lythgoe M.F., et al. Mitochondrial cyclophilin-D as a potential therapeutic target for post-myocardial infarction heart failure. J Cell Mol Med 2011, 15:2443-2451.
25. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
26. Inserte J., Hernando V., Vilardosa U., Abad E., Poncelas-Nozal M., Garcia-Dorado D. Activation of cGMP/protein kinase G pathway in postconditioned myocardium depends on reduced oxidative stress and preserved endothelial nitric oxide synthase coupling. J Am Heart Assoc 2013, 2. [e005975].
27. Schwartz Longacre L., Kloner R.A., Arai A.E., Baines C.P., Bolli R., Braunwald E., et al. New horizons in cardioprotection: recommendations from the 2010 National Heart, Lung, and Blood Institute Workshop. Circulation 2011, 124:1172-1179.
28. Lecour S., Botker H.E., Condorelli G., Davidson S.M., Garcia-Dorado D., Engel F.B., et al. ESC working group cellular biology of the heart: position paper: improving the preclinical assessment of novel cardioprotective therapies. Cardiovasc Res 2014, 104:399-411.
29. Hull R.L., Kodama K., Utzschneider K.M., Carr D.B., Prigeon R.L., Kahn S.E. Dietary-fat-induced obesity in mice results in beta cell hyperplasia but not increased insulin release: evidence for specificity of impaired beta cell adaptation. Diabetologia 2005, 48:1350-1358.
30. Surwit R.S., Feinglos M.N., Rodin J., Sutherland A., Petro A.E., Opara E.C., et al. Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. Metabolism 1995, 44:645-651.
31. Zeng H., Vaka V.R., He X., Booz G.W., Chen J.X. High-fat diet induces cardiac remodelling and dysfunction: assessment of the role played by SIRT3 loss. J Cell Mol Med 2015, 10.1111/jcmm.12556.
32. Wilson C.R., Tran M.K., Salazar K.L., Young M.E., Taegtmeyer H. Western diet, but not high fat diet, causes derangements of fatty acid metabolism and contractile dysfunction in the heart of Wistar rats. Biochem J 2007, 406:457-467.
33. Brainard R.E., Watson L.J., Demartino A.M., Brittian K.R., Readnower R.D., Boakye A.A., et al. High fat feeding in mice is insufficient to induce cardiac dysfunction and does not exacerbate heart failure. PLoS One 2013, 8. [e83174].
34. Calligaris S.D., Lecanda M., Solis F., Ezquer M., Gutierrez J., Brandan E., et al. Mice long-term high-fat diet feeding recapitulates human cardiovascular alterations: an animal model to study the early phases of diabetic cardiomyopathy. PLoS One 2013, 8. [e60931].
35. Lopez E.F., Kabarowski J.H., Ingle K.A., Kain V., Barnes S., Crossman D.K., et al. Obesity superimposed on aging magnifies inflammation and delays the resolving response after myocardial infarction. Am J Physiol Heart Circ Physiol 2015, 308:H269-H280.
36. Singh V.P., Le B., Khode R., Baker K.M., Kumar R. Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis. Diabetes 2008, 57:3297-3306.
37. Huisamen B., Dietrich D., Bezuidenhout N., Lopes J., Flepisi B., Blackhurst D., et al. Early cardiovascular changes occurring in diet-induced, obese insulin-resistant rats. Mol Cell Biochem 2012, 368:37-45.
38. Haar L., Ren X., Liu Y., Koch S.E., Goines J., Tranter M., et al. Acute consumption of a high-fat diet prior to ischemia-reperfusion results in cardioprotection through NF-kappaB-dependent regulation of autophagic pathways. Am J Physiol Heart Circ Physiol 2014, 307:H1705-H1713.
39. Thakker G.D., Frangogiannis N.G., Bujak M., Zymek P., Gaubatz J.W., Reddy A.K., et al. Effects of diet-induced obesity on inflammation and remodeling after myocardial infarction. Am J Physiol Heart Circ Physiol 2006, 291:H2504-H2514.
40. Liu J., Lloyd S.G. High-fat, low-carbohydrate diet alters myocardial oxidative stress and impairs recovery of cardiac function after ischemia and reperfusion in obese rats. Nutr Res 2013, 33:311-321.
41. Salie R., Huisamen B., Lochner A. High carbohydrate and high fat diets protect the heart against ischaemia/reperfusion injury. Cardiovasc Diabetol 2014, 13:109.
42. Cook SA, Varela-Carver A, Mongillo M, Kleinert C, Khan MT, Leccisotti L, et al. Abnormal myocardial insulin signalling in type 2 diabetes and left-ventricular dysfunction. Eur Heart J.31:100-11.
43. Sharma V., Kearney M.T., Davidson S.M., Yellon D.M. Endothelial insulin resistance protects the heart against prolonged ischemia-reperfusion injury but does not prevent insulin transport across the endothelium in a mouse langendorff model. J Cardiovasc Pharmacol Ther 2014, 19:586-591.
44. Ji L., Fu F., Zhang L., Liu W., Cai X., Zhang L., et al. Insulin attenuates myocardial ischemia/reperfusion injury via reducing oxidative/nitrative stress. Am J Physiol Endocrinol Metab 2010, 298:E871-E880.
45. Wong V.W., Mardini M., Cheung N.W., Mihailidou A.S. High-dose insulin in experimental myocardial infarction in rabbits: protection against effects of hyperglycaemia. J Diabetes Complications 2011, 25:122-128.
46. Sato T., Sato H., Oguchi T., Fukushima H., Carvalho G., Lattermann R., et al. Insulin preconditioning elevates p-Akt and cardiac contractility after reperfusion in the isolated ischemic rat heart. Biomed Res Int 2014, 2014:536510.
47. Zhang H.X., Zang Y.M., Huo J.H., Liang S.J., Zhang H.F., Wang Y.M., et al. Physiologically tolerable insulin reduces myocardial injury and improves cardiac functional recovery in myocardial ischemic/reperfused dogs. J Cardiovasc Pharmacol 2006, 48:306-313.
48. Zhang H.F., Fan Q., Qian X.X., Lopez B.L., Christopher T.A., Ma X.L., et al. Role of insulin in the anti-apoptotic effect of glucose-insulin-potassium in rabbits with acute myocardial ischemia and reperfusion. Apoptosis 2004, 9:777-783.
49. Diaz R., Paolasso E.A., Piegas L.S., Tajer C.D., Moreno M.G., Corvalan R., et al. Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiologicos Latinoamerica) Collaborative Group. Circulation 1998, 98:2227-2234.
50. Malmberg K. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ 1997, 314:1512-1515.
51. Selker H.P., Udelson J.E., Massaro J.M., Ruthazer R., D'Agostino R.B., Griffith J.L., et al. One-year outcomes of out-of-hospital administration of intravenous glucose, insulin, and potassium (GIK) in patients with suspected acute coronary syndromes (from the IMMEDIATE [Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care] Trial). Am J Cardiol 2014, 113:1599-1605.
52. Yu Q., Gao F., Ma X.L. Insulin says NO to cardiovascular disease. Cardiovasc Res 2011, 89:516-524.
53. Teshima Y., Takahashi N., Thuc L.C., Nishio S., Nagano-Torigoe Y., Miyazaki H., et al. High-glucose condition reduces cardioprotective effects of insulin against mechanical stress-induced cell injury. Life Sci 2010, 87:154-161.
54. van Bilsen M., Smeets P.J., Gilde A.J., van der Vusse G.J. Metabolic remodelling of the failing heart: the cardiac burn-out syndrome?. Cardiovasc Res 2004, 61:218-226.
55. Ussher J.R., Koves T.R., Jaswal J.S., Zhang L., Ilkayeva O., Dyck J.R., et al. Insulin-stimulated cardiac glucose oxidation is increased in high-fat diet-induced obese mice lacking malonyl CoA decarboxylase. Diabetes 2009, 58:1766-1775.
56. Den Ruijter H.M., Verkerk A.O., Schumacher C.A., Houten S.M., Belterman C.N., Baartscheer A., et al. A diet rich in unsaturated fatty acids prevents progression toward heart failure in a rabbit model of pressure and volume overload. Circ Heart Fail 2012, 5:376-384.
57. Lopaschuk G.D., Spafford M.A., Davies N.J., Wall S.R. Glucose and palmitate oxidation in isolated working rat hearts reperfused after a period of transient global ischemia. Circ Res 1990, 66:546-553.
58. Dyck J.R., Cheng J.F., Stanley W.C., Barr R., Chandler M.P., Brown S., et al. Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation. Circ Res 2004, 94:e78-e84.